Search - tctmd.com

Displaying 21 - 40 of 59

Sort: Relevancy | Date

Presentation TCT 2023

Imaging of Patients With Failed Mitral Bioprostheses: The ABCs of MVIV TMVR

Presenter: Joao Cavalcante

October 24, 2023

Presentation TCT 2023

EVOLVED: CMR As an Early Marker of Risk

Presenter: Joao Cavalcante

October 24, 2023

News Daily News

Cardiac MR Noninferior to CT for TAVI Planning, Small RCT Shows

Yael L. Maxwell

September 15, 2023

Presentation TVT 2023

Imaging Pre-Screening in TMVR Trials: Where are the Anatomical Challenges?

Presenter: Joao Cavalcante

June 09, 2023

Presentation TVT 2023

Diagnosis, and Imaging Findings in HALT and THV Thrombosis (Workup of Elevated Gradients)

Presenter: Joao Cavalcante

June 08, 2023

Presentation TVT 2023

Using CMR Imaging to Identify High-Risk Severe AS Patients (Introduction to the EVOLVED Study)

Presenter: Joao Cavalcante

June 08, 2023

News Featured Fellow

Daniel Shpilsky, MD

Yael L. Maxwell

March 31, 2023

News Daily News

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Michael O'Riordan

March 29, 2023

News Daily News

Radiation Exposure Highest for Interventional Imagers at Right Waist and Below

Yael L. Maxwell

March 29, 2023

Presentation TCT 2022

TEER Planning: Real-World Situations Where Multi-Modality Imaging Is Recommended (Case-Based)

Presenter: Joao L. Cavalcante

September 19, 2022

Presentation TCT 2022

Leaflet Design's Impact on Physiology

Presenter: Joao Cavalcante

September 18, 2022

Presentation TCT 2022

HALT and HAM: Harmless Bystander or Long-Term Danger?

Presenter: Joao Cavalcante

September 17, 2022

Presentation TCT 2022

Advanced Imaging

Presenter: Joao L. Cavalcante

September 16, 2022

News Daily News

CMR Could Refine Early Management Decisions in Aortic Regurgitation

L.A. McKeown

July 27, 2022

Presentation TVT 2022

HALT and PVL

Presenter: Joao L. Cavalcante

June 09, 2022

Presentation TVT 2022

Prognosticating With Imaging, Part 1: Leveraging TAVR CT Analysis for Patient Risk Stratification

Presenter: Joao Cavalcante

June 08, 2022

Presentation TVT 2022

Case-based Risk Stratification: Bridge too Far – Role of Multi-modality Assessment for Patient Selection

Presenter: Joao Cavalcante

June 08, 2022

News Conference News PCR London Valves 2021

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

Shelley Wood

November 26, 2021

Presentation TVT 2021

My Top Picks: Innovation that will Shape the Future of Cardiac Imaging for Trans-Catheter Valve Therapies

Presenter: João Cavalcante

July 21, 2021

Presentation TVT 2021

Assessment of Valvular Heart Disease Severity: Limitations and Opportunities for the Development of Advanced Analytical Algorithms

Presenter: João Cavalcante

July 21, 2021

Advertisement

Imaging of Patients With Failed Mitral Bioprostheses: The ABCs of MVIV TMVR

EVOLVED: CMR As an Early Marker of Risk

Cardiac MR Noninferior to CT for TAVI Planning, Small RCT Shows

Imaging Pre-Screening in TMVR Trials: Where are the Anatomical Challenges?

Diagnosis, and Imaging Findings in HALT and THV Thrombosis (Workup of Elevated Gradients)

Using CMR Imaging to Identify High-Risk Severe AS Patients (Introduction to the EVOLVED Study)

Daniel Shpilsky, MD

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Radiation Exposure Highest for Interventional Imagers at Right Waist and Below

TEER Planning: Real-World Situations Where Multi-Modality Imaging Is Recommended (Case-Based)

Leaflet Design's Impact on Physiology

HALT and HAM: Harmless Bystander or Long-Term Danger?

Advanced Imaging

CMR Could Refine Early Management Decisions in Aortic Regurgitation

HALT and PVL

Prognosticating With Imaging, Part 1: Leveraging TAVR CT Analysis for Patient Risk Stratification

Case-based Risk Stratification: Bridge too Far – Role of Multi-modality Assessment for Patient Selection

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

My Top Picks: Innovation that will Shape the Future of Cardiac Imaging for Trans-Catheter Valve Therapies

Assessment of Valvular Heart Disease Severity: Limitations and Opportunities for the Development of Advanced Analytical Algorithms

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content